Drs Neil Lawrence, of Sheffield Children's Hospital NHS Foundation Trust in Sheffield, England; Hafeez Shaka, MD, of John H. Stroger Jr. Hospital, Cook County, Chicago; and Manish Raisingani, MD, an assistant professor at the University of Arkansas for Medical Sciences/Arkansas Children’s Hospital, discuss the impact of the COVID-19 lockdown on the management of blood sugar in patients with type 1 diabetes. They also discuss the impact of COVID-19 restrictions on hospital readmission rates for diabetic ketoacidosis and the risk of complications in children with type 1 diabetes.